Polycythemia Vera
📧 Sign up to get email alerts when something new happens for Polycythemia Vera.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU [Phase 2]
Phase 2 study evaluating the efficacy and safety of P1101 in Chinese patients with polycythemia vera who are intolerant or resistant to hydr…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera [Phase 4]
This clinical trial update reports on a Phase 4 study of Ropeginterferon alfa-2b (P1101) for polycythemia vera, focusing on efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: A Study of Bomedemstat (MK-3543) in Participants With Polycythemia Vera (MK-3543-004) [Phase 2]
The Phase 2 MK-3543-004 trial evaluating Bomedemstat in polycythemia vera has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia [Phase 2]
Phase 2 clinical trial (Ruxo-BEAT) evaluating ruxolitinib in high-risk polycythemia vera or high-risk essential thrombocythemia; the study i…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV) [Phase 1]
Phase 1 clinical trial update for BEBT-507 Injection in Polycythemia vera; the study is currently NOT_YET_RECRUITING.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History [NA]
This clinical trial update describes a study assessing the prevalence of germline gene mutations in patients with myeloproliferative neoplas…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera [Phase 1]
A Phase 1 study evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of 9MW3011 in patients with polycyth…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders [Phase 1]
Phase 1 study of Veliparib with Topotecan, with or without Carboplatin, in relapsed or refractory acute leukemias, high-risk myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia [Phase 2]
Phase 2 clinical trial update from Bristol-Myers Squibb evaluating SAR302503 in polycythemia vera or essential thrombocythemia; the study st…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms
This clinical trial investigates how extracellular vesicle–driven senescence contributes to myeloproliferative neoplasms, including essentia…
-
CLINICAL_TRIALS other · 2025-01-21Clinical Trial Update: EVAluation of Erythrocytosis PRospEctive Cohort STudy
A registry entry for a prospective cohort study evaluating erythrocytosis and polycythemia that is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Efficacy and Safety of Peginterferon in ET and PV. [NA]
This document reports a currently recruiting clinical trial evaluating the efficacy and safety of peginterferon in essential thrombocythemia…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
A recruiting clinical trial is evaluating ruxolitinib in patients with myelofibrosis, including primary myelofibrosis and myelofibrosis seco…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera [Phase 3]
A Phase 3 trial comparing ruxolitinib to hydroxycarbamide or interferon as first-line therapy for high-risk polycythemia vera, currently rec…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study to Evaluate P1101 in Japanese PV Patients [Phase 3]
Phase 3 study evaluating P1101 in Japanese patients with Polycythemia Vera has completed.
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients [Phase 3]
An extension study of P1101 is planned after completion of Phase 2 in polycythemia vera or Phase 3 in essential thrombocythemia; the trial i…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Aquagenic Pruritus in Myeloproliferative Neoplasms
A completed clinical trial investigating aquagenic pruritus in patients with myeloproliferative neoplasms.
-
FDA approval · 2024-09-23FDA Approved: HYDROXYUREA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Hydroxyurea, confirming an updated approval for the generic produ…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV [Phase 2]
Phase 2 trial update reporting results for AOP2014 in low-risk polycythemia vera patients, detailing its benefit/risk profile.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213) [Phase 2]
Phase 2 LIMBER-213 evaluated the safety, tolerability, and efficacy of Itacitinib immediate-release tablets in adults with primary or second…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Myeloproliferative Neoplasms (MPNs) Patient Registry
An update on the Myeloproliferative Neoplasms (MPNs) Patient Registry sponsored by University Health Network in Toronto, currently recruitin…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Myeloproliferative Neoplastic Diseases Observatory From Brest
A Brest-based clinical trial observatory update for myeloproliferative neoplasms, enrolling patients with polycythemia vera, essential throm…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Clinical and Laboratory Characteristics of Polycythemia Vera
This completed clinical trial investigated the clinical and laboratory characteristics of polycythemia vera, reported by IRCCS Azienda Osped…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV [Phase 2]
Phase 2 trial evaluating the combination of pegylated interferon α-2b with ruxolitinib for hydroxyurea-resistant or intolerant polycythemia …
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea [Phase 1]
This Phase 1 trial evaluated the combination of TGR-1202 and ruxolitinib in patients with myelofibrosis and polycythemia vera who are resist…